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Exploring functionality of the reverse 
β-oxidation pathway in Corynebacterium 
glutamicum for production of adipic acid
Jae Ho Shin1, Aaron John Christian Andersen2, Puck Achterberg1,3 and Lisbeth Olsson1*  
Abstract 
Background: Adipic acid, a six-carbon platform chemical mainly used in nylon production, can be produced via 
reverse β-oxidation in microbial systems. The advantages posed by Corynebacterium glutamicum as a model cell 
factory for implementing the pathway include: (1) availability of genetic tools, (2) excretion of succinate and acetate 
when the TCA cycle becomes overflown, (3) initiation of biosynthesis with succinyl-CoA and acetyl-CoA, and (4) 
established succinic acid production. Here, we implemented the reverse β-oxidation pathway in C. glutamicum and 
assessed its functionality for adipic acid biosynthesis.
Results: To obtain a non-decarboxylative condensation product of acetyl-CoA and succinyl-CoA, and to subse-
quently remove CoA from the condensation product, we introduced heterologous 3-oxoadipyl-CoA thiolase and 
acyl-CoA thioesterase into C. glutamicum. No 3-oxoadipic acid could be detected in the cultivation broth, possibly 
due to its endogenous catabolism. To successfully biosynthesize and secrete 3-hydroxyadipic acid, 3-hydroxyadipyl-
CoA dehydrogenase was introduced. Addition of 2,3-dehydroadipyl-CoA hydratase led to biosynthesis and excretion 
of trans-2-hexenedioic acid. Finally, trans-2-enoyl-CoA reductase was inserted to yield 37 µg/L of adipic acid.
Conclusions: In the present study, we engineered the reverse β-oxidation pathway in C. glutamicum and assessed its 
potential for producing adipic acid from glucose as starting material. The presence of adipic acid, albeit small amount, 
in the cultivation broth indicated that the synthetic genes were expressed and functional. Moreover, 2,3-dehydroad-
ipyl-CoA hydratase and β-ketoadipyl-CoA thiolase were determined as potential target for further improvement of the 
pathway.
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco 
mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Introduction
The detrimental impact of petrochemical-based manu-
facturing on the environment has increased demand for 
biomass-derived chemicals, fuels, and consumer prod-
ucts [1, 2]. Biomass-based derived compounds now 
include fuels [3], monomers [4], polymers [5], and phar-
maceuticals [2], with a few products already exerting a 
significant impact in the chemical industry [6, 7]. Global 
ongoing efforts are focused on expanding the portfolio, 
as well as increasing titers and yield.
Adipic acid, an aliphatic dicarboxylic acid, has gained 
wide attention from the metabolic engineering commu-
nity as a six-carbon platform chemical for more than 
two decades [8]. Adipic acid is used as a building block 
for nylon-6,6, as well as other fibers, polyesters, and 
resins [9]. Its industrial production volume amounts to 
nearly 3  million US tons and is achieved via chemical 
oxidation of petroleum-derived KA oil (cyclohexanone 
and cyclohexanol) [10]. The petroleum-dependent 
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search for sustainable adipic acid precursors, deriva-
tives, and analogues [11–13].
While bio-based production of adipic acid had been 
hampered by lack of efficient pathways, both syn-
thetic [14–20] and naturally occurring pathways [21] 
have been characterized. Thermobifida fusca [21], as 
well as engineered Escherichia coli [14–20, 22], Sac-
charomyces cerevisiae [10], and Pseudomonas putida 
[23] can generate adipic acid from bio-based carbon 
sources, such as glucose or glycerol. As reviewed previ-
ously [9, 24–27], successful biosynthesis of adipic acid 
has often exploited the reverse β-oxidation pathway. 
This pathway is a synthetic extension of the tricarbo-
xylic acid (TCA) cycle, has favorable thermodynam-
ics (−  78.4  kJ/mol) [19], and leads to biosynthesis of 
coenzyme A (CoA)-activated intermediates via con-
densation of TCA metabolites, succinyl-CoA and 
acetyl-CoA. Whereas glycerol is an especially good car-
bon source for the production of adipic acid via reverse 
β-oxidation [15], the same has not been demonstrated 
for glucose. Reverse β-oxidation genes from combina-
torial genetic sources have been applied in E. coli due 
to its relatively easy engineering [14, 16–19], whereas 
native adipic acid metabolic pathways have been iden-
tified in T. fusca [21]. Since the demonstration of adi-
pic acid production from glucose in T. fusca, reverse 
β-oxidation genes from this bacterium have been 
applied in E. coli to attain high-titer adipic acid produc-
tion from glycerol [15]. To further improve adipic acid 
titers from monosaccharides and ultimately lignocellu-
losic materials, new strategies are required.
Corynebacterium glutamicum is an established indus-
trial workhorse for producing amino acids, such as 
L-glutamate [28] and L-lysine [29, 30]. New genetic 
engineering and bioinformatics tools have expanded 
the chemical product portfolio of C. glutamicum to 
include L-valine [31], pinene [32], diaminopentane [29], 
γ-aminobutyrate [33], 5-amiovaleric acid [34, 35], glutaric 
acid [36], alcohols [37], resveratrol [38], and muconic 
acid [39, 40]. Given that, unlike E. coli, C. glutamicum 
does not naturally consume glycerol [41], the majority of 
aforementioned studies on C. glutamicum have focused 
on simple sugars as carbon sources. Notably, bio-based 
production of 1,5-diaminopentane [42], 5-aminovaleric 
acid, and glutaric acid [43] has achieved higher titers in 
C. glutamicum than in E. coli [34–36, 44], likely due to 
higher metabolic flux toward amino acids in the former 
species [29]. Furthermore, engineered C. glutamicum can 
produce industrial titers of succinic acid (up to 146 g/L) 
[45], greatly surpassing other organisms [46]. Because 
the reverse β-oxidation pathway begins with TCA cycle 
intermediates and extensive amounts of succinic acid 
can be generated in C. glutamicum [47], introduction of 
adipic acid biosynthesis pathways in this organism has 
been proposed here in this study.
In the present study, we explored the generation of 
adipic acid using C. glutamicum as proof-of-concept 
cell factory. While adipic acid production from glucose 
has been attempted mostly in E. coli [14–20], develop-
ment of other organisms may lead to potential improve-
ments. To this end, we designed a synthetic pathway 
consisting of five heterologous genes (Fig. 1) and imple-
mented reverse β-oxidation in C. glutamicum using 
glucose as carbon source. According to the designed 
scheme, E. coli 3-oxoadipyl-CoA thiolase (PaaJ; E.C. 
2.3.1.174) [14, 16, 19] catalyzes the condensation of 
acetyl-CoA and succinyl-CoA to form a six-carbon back-
bone. Next, the resulting 3-oxoadipyl-CoA is reduced by 
E. coli 3-hydroxyacyl-CoA dehydrogenase (PaaH; E.C. 
1.1.1.157), and then dehydrated by E. coli 2,3-dehydroad-
ipyl-CoA hydratase (PaaF; E.C. 4.2.1.17) [16, 19]. Subse-
quently, reduction by trans-2-enoyl-CoA reductase (Ter; 
E.C. 1.3.1.44) from Treponema denticola [48] is followed 
by release of CoA via thioesterase (TesB) from Acineto-
bacter baylyi [49] to finally yield adipic acid (Fig. 1).
Results
Assessment of non‑decarboxylative Claisen condensation 
of acetyl‑CoA and succinyl‑CoA in C. glutamicum 
by overexpressing paaJ from E. coli
The design of synthetic pathway (Fig.  1) is motived by 
the similarities found in the bacterial phenylalanine 
catabolism pathways. Catabolism of phenylalanine in E. 
coli and styrene in Pseudomonas proceed via phenylac-
etate degradation [50–52]. In the last steps of phenylac-
etate catabolism, 2,3-dehydroadipyl-CoA is hydrated to 
3-hydroxyadipyl-CoA, which is then oxidized to yield 
3-oxoadipyl-CoA. Subsequently, succinyl-CoA and 
acetyl-CoA formed by thiolytic cleavage of 3-oxoadipyl-
CoA are assimilated in the TCA cycle. Overexpression 
of E. coli paaF, paaH, and paaJ genes involved in these 
steps previously has demonstrated not only the revers-
ibility of the individual enzymes, but also that of the 
pathway’s direction [16, 19]. Additionally, CoA-released 
byproducts of the abovementioned pathway, including 
3-oxoadipate, 3-hydroxyadipate, and trans-2-hexenedio-
ate, have been observed in the cultivation broth of E. coli 
overexpressing paaJ, paaH, and paaF [19]. While reverse 
β-oxidation may function through multiple cycles [53], 
PaaJ was shown to stop after the first cycle when overex-
pressed in E. coli, thus preventing the formation of C8 or 
C10 compounds [16]. Accordingly, here, E. coli PaaJ was 
chosen as the first reaction step (Fig. 1).
To assess whether non-decarboxylative Claisen con-
densation of succinyl-CoA and acetyl-CoA into 3-oxoad-
ipyl-CoA occurred in C. glutamicum, the E. coli paaJ 
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gene (KEGG ID: JW1392) was cloned into pZ8-Ptac 
(Fig.  1; Additional file  1: Table  S1, Additional file  2: 
Table  S2), an E. coli-C. glutamicum shuttle vector [54], 
and the CoA-released byproduct of 3-oxoadipyl-CoA 
was measured. TesB from A. baylyi is thought to have a 
broad substrate specificity and is known to release CoA 
from 3-oxoadipyl-CoA [19]. Similarly, E. coli thioester-
ase, which shares 43 % identity with A. baylyi TesB, has 
been shown to release adipic acid from adipyl-CoA at 
its endogenous basal expression level [16]. Thus, tesB 
from A. baylyi and paaJ from E. coli were organized in 
an operon behind the native tac promoter in the pZ8-
paaJ-tesB vector (Fig.  1;  Additional file  1: Table  S1). C. 
glutamicum was transformed with pZ8-paaJ-tesB and 
its growth and capability to synthesize 3-oxoadipic acid 
by flask-batch cultivation were assessed (Fig. 2a). C. glu-
tamicum harboring pZ8-paaJ-tesB reached  OD600 of 
26.4 after 72 h. The metabolites excreted in the cultiva-
tion broth were derivatized with O-methylhydroxylamine 
(MeOX), and N-methyl-N-(trimethylsilyl)trifluoroaceta-
mide (MSTFA), and analyzed by GC/MS. As 3-oxoadipic 
acid could not be detected (Additional file 3: Fig. S1), we 
speculated that it was metabolized and, instead, decided 
to measure the next byproduct of the pathway.
Demonstration of 3‑hydroxyadipate biosynthesis 
from engineered C. glutamicum
To biosynthesize and detect 3-hydroxyadipate (Fig.  1), 
we cloned paaJ, tesB, and a codon-optimized version of 
E. coli paaH (KEGG ID: JW1390) in the pZ8-Ptac back-
bone. 3-hydroxyadipate has previously been detected in 
recombinant E. coli [19]. To ensure sufficient expression 
of paaJ, tesB, and paaH from a vector-based operon in 
C. glutamicum [35], the new pZ8-paaH-tesB-paaJ plas-
mid included an extra tac promoter [55]. The latter was 
added to the native tac promoter upstream of paaJ to 
ensure expression of paaJ and paaH. Owing to possi-
ble activity of endogenous C. glutamicum thioesterases, 
the tesB gene accompanied by an additional ribosome-
binding site (RBS) was placed downstream of paaH. 
C. glutamicum transformed with pZ8-paaH-tesB-
paaJ reached  OD600 of 24.3 after 72  h of flask-batch 
Fig. 1 Reverse β-oxidation pathway for adipic acid biosynthesis from TCA metabolites. a Synthetic pathway designed to enable adipic acid 
biosynthesis from succinyl-CoA and acetyl-CoA. Five enzymatic steps, including condensation, reduction, dehydration, second reduction, 
and hydrolysis of a thioester bond, are carried out by paaJ, paaH, paaF, ter, and tesB gene products encoding the E. coli PaaJ thiolase, PaaH 
3-hydroxyacyl-CoA dehydrogenase, PaaF 2,3-dehydroadipyl-CoA hydratase, Ter trans-2-enoyl-CoA reductase, and TesB thioesterase. PcaF 
corresponds to a putative acetyl-CoA:acetyltransferase. b Vector design to investigate pathway intermediate compounds
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cultivation (Fig. 2b). MSTFA derivatization of the culti-
vation broth followed by GC/MS revealed the presence 
of 3-hydroxyadipic acid among excreted metabolites 
(Fig.  2c, d). The retention time of trimethylsilyl-3-hy-
droxyadipic acid was 13.3 min under our experimental 
conditions. The m/z pattern of the compound matched 
that of the MSTFA-reacted 3-hydroxyadipic acid stand-
ard (Additional file  4: Fig. S2). These findings demon-
strated successful heterologous overexpression of paaJ, 
paaH, and tesB, resulting in production and excretion 
of 3-hydroxyadipate from engineered C. glutamicum. 
Moreover, the presence of 3-hydroxyadipic acid in 
the cultivation broth indirectly confirmed the correct 
functioning of PaaJ and condensation of acetyl-CoA 
and succinyl-CoA in engineered C. glutamicum. Thus, 
overexpression of PaaJ in C. glutamicum allows manip-
ulation of the thermodynamic equilibrium between 
acetyl-CoA, succinyl-CoA, and 3-oxoadipyl-CoA, in 
spite of endogenous β-ketoadipyl CoA thiolase (PcaF), 
which is thought to promote the catabolic direction of 
the pathway [56].
Demonstration of trans‑2‑hexenedioic acid 
from engineered C. glutamicum
For trans-2-hexenedioic acid biosynthesis in C. glu-
tamicum, PaaF (KEGG ID: b1393) from E. coli [50] was 
added to pZ8-paaH-tesB-paaJ. The resulting vector was 
named pZ8-paaH-tesB-paaJF and transformed into C. 
glutamicum. PaaF from E. coli catalyzes the dehydration 
of 3-hydroxyadipyl-CoA [16, 19], forming 2,3-dehydroad-
ipyl-CoA. The CoA-released form of the latter com-
pound, trans-2-hexenedioic acid, has been detected from 
an engineered E. coli strain [19].
The engineered C. glutamicum strain expressing the 
four genes reached  OD600 of 24.8 after 72  h shake-flask 
cultivation (Fig. 3a). Concentrating the cultivation broth 
5-fold using solid-phase extraction followed by LC/MS 
revealed presence of trans-2-hexenedioic acid (Fig.  3b). 
Fig. 2 Biosynthesis of adipic acid pathway intermediates from glucose. Shake-flask cultivation profile of C. glutamicum harboring (a) pZ8-paaJ-tesB 
and (b) pZ8-paaH-tesB-paaJ.  OD600 (filled circles), residual sugar (empty circles). N = 3; error bars = standard deviation. c Representative GC/MS ion 
(m/z = 363) extracted chromatogram of MSTFA-derivatized cultivation broth from C. glutamicum transformed with pZ8-paaH-tesB-paaJ. The peak 
at retention time 13.3 min corresponds to MSTFA-derivatized 3-hydroxyadipic acid. (d) m/z fragmentation pattern of the peak corresponding to 
MSTFA-derivatized 3-hydroxyadipic acid from (c)
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C. glutamicum strain harboring pZ8-paaH-tesB-paaJ did 
not produce detectable amount of trans-2-hexenedioic 
acid (Fig. 3b). The results indirectly demonstrated expres-
sion of paaJ, paaH, paaF, and tesB genes despite the 
operon organization with placing paaF and tesB at the 
downstream of each operon (Fig. 1). Downstream genes 
are known to be expressed weaker than the upstream 
genes in operon configurations [57]. However, the results 
also suggested that either expression of operons was not 
optimal for downstream genes or there was a bottleneck 
in the pathway.
Implementation of full‑length reverse β‑oxidation in C. 
glutamicum
Addition of Ter from T. denticola [48] completed the 
reverse β-oxidation pathway for adipic acid production 
in C. glutamicum (Fig. 1). Overexpression of ter from T. 
denticola (KEGG ID: TDE0597) was shown to reduce 
trans-2-enoyl-CoA in engineered E. coli [16]. To express 
codon-optimized paaJ, paaH, paaF, ter, and tesB on a 
single vector, the genes were reorganized in two separate 
operons, each driven by a tac promoter and constructed 
in such a way that paaF was expressed after paaJ and ter 
after paaH. Expression of tesB was again given the lowest 
priority and was placed in the last position of the second 
operon, downstream of paaF. Translation of paaF, ter, 
and tesB was enabled by each accompanying synthetic 
RBS. C. glutamicum transformed with the resulting pZ8-
paaH-ter-paaJ-paaF-tesB plasmid reached  OD600 of 25.2 
after 78  h of flask-batch cultivation (Fig.  4a). MSTFA 
derivatization of the cultivation broth followed by GC/
MS revealed the presence of 3-hydroxyadipate (Fig.  4b, 
c) but not trans-2-hexenedioic acid or adipic acid. How-
ever, concentrating cultivation broth 5-fold followed 
by LC-MS revealed presence of 37.3 µg/L of adipic acid 
(Fig.  4d). Analysis of LC-MS/MS further confirmed the 
identity of adipic acid from the cultivation broth (Addi-
tional file  5: Fig. S3). The MS/MS spectra obtained was 
also in agreement with publicly available database entry 
(HMDB0000448) [58]. C. glutamicum harboring an 
empty vector also reached  OD600 of 25.2 (Fig.  4c), and 
no intermediate compounds were detected in the con-
trol strain (Fig.  4b-d). The presence of an intermediate 
and adipic acid confirmed that even when tesB expres-
sion was given the least priority, release of CoA was not 
hindered by the pZ8-paaH-ter-paaJ-paaF-tesB construct. 
A possible reason for this is that native thioesterase (i.e., 
NCgl1600) activity was strong enough to release CoA 
from 3-hydroxyadipyl-CoA or that expression and func-
tionality of tesB were achieved. However, these results 
also pointed to the need for a new strategy to assess 
and improve gene expression of the attempted synthetic 
pathway.
Discussion
In this study, we aimed to investigate the reverse 
β-oxidation pathway and its functionality in engi-
neered C. glutamicum. In the final strain, detection of 
3-hydroxyadipic acid as major byproduct, small amount 
of adipic acid, and concomitant absence of trans-
2-hexenedioic acid pointed to inefficient PaaF activity, 
although Ter functionality should be assessed separately 
as well (Figs. 3, 4). Such pattern indicated that the dehy-
dration of 3-hydroxyadipyl-CoA was the bottleneck 
step. The paaF and ter genes were each placed down-
stream in the respective operons (Fig.  1), since placing 
the upstream pathway genes in the upstream of operon 
organization has proven advantageous [34, 35]. This also 
might have led to decreased expression of paaF. Hence, a 
possible strategy to overcome the expression challenge is 
Fig. 3 Shake-flask cultivation profile of C. glutamicum harboring pZ8-paaH-tesB-paaJF. a Cultivation profile including  OD600 (filled circle) and 
residual sugar (empty circle). N = 3; error bars = standard deviation. b Ion (m/z = 143.03498) extracted chromatogram obtained by LC/MS of 
trans-2-hexenedioic acid (blue), cultivation broth of C. glutamicum harboring pZ8-paaH-tesB-paaJF (grey), and a control vector (black)
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to switch the operon organization or to place additional 
promoters for improved paaF and ter expression [57]. 
A potential strategy to overcome dehydration step is to 
use another enzyme, such as Ech (enoyl-CoA hydratase) 
from Ralstonia eutropha, Crt (crotonase) from Clostrid-
ium acetobutylicum [14], or Tfu_0067 from T. fusca [15], 
as it might be that E. coli PaaF is simply less compatible 
with C. glutamicum for some unknown reason.
Lack of 3-oxoadipic acid in the cultivation broth can 
be potentially explained by the presence of PcaF, which 
is encoded by cg2625 (EC:2.3.1.9) and involved in deg-
radation of 3-oxoadipic acid [59]. Although paaJ over-
expression might have allowed an equilibrium between 
3-oxoadipyl-CoA, acetyl-CoA, and succinyl-CoA, PcaF 
could have represented a potential source of disturbance 
by reversing the direction of the chemical reaction. We 
speculate that PcaF acts against PaaJ to actively degrade 
3-oxoadipyl-CoA. Furthermore, because 3-oxoadipic 
acid synthesized in the presence of PaaJ and TesB can be 
reverted to 3-oxoadipyl-CoA by PcaIJ [59], chromosomal 
deletion of pcaIJ and pcaF appears necessary to prevent 
degradation of 3-oxoadipyl-CoA and 3-oxoadipic acid.
Once bottleneck step of the dehydration of 
3-hydroxyadipyl-CoA is overcome, further strategies to 
improve adipic acid production might include expres-
sion optimization by engineering the reductive branch 
of TCA cycle [60], RBS switching [61], alternating 
reducing equivalents between  NADH+ and NADPH 
[62], media engineering [63], eliminating competing 
pathways [64], using a different thioesterase for CoA 
removal [24], and removing any pathways leading to 
the formation of byproducts [65]. A switch in reduc-
ing equivalent can be achieved using trans-2-enoyl-
CoA reductase (E.C. 1.3.1.38), which accepts NADPH, 
an abundant cofactor in C. glutamicum. Competing 
reaction can be eliminated by deleting pcaF, because 
the reverse degradation flux must be engineered to 
overcome the catabolic step [66]. Possible strain and 
pathway engineering strategies to improve titer and 
productivity have been discussed previously [67–69].
C. glutamicum offers various benefits, such as elevated 
tolerance to acids, strong TCA flux, and natural excretion 
of acetic and succinic acid upon metabolic stress. Its use 
of acetyl-CoA and succinyl-CoA in the initial steps was 
hypothesized to favor adipic acid production. However, 
while condensation of acetyl-CoA and succinyl-CoA was 
indeed successful, directing the flux toward adipic acid 
proved either impossible or insufficient. Hence, several 
Fig. 4 Shake-flask cultivation profile of C. glutamicum harboring pZ8-paaH-ter-paaJ-paaF-tesB. a Cultivation parameters include  OD600 (filled 
circles) and residual sugar (empty circles). N = 3; error bars = standard deviation. b Ion (m/z = 363) extracted chromatogram obtained by GC/MS 
of the cultivation broth (t = 55 h) of C. glutamicum harboring pZ8-paaH-ter-paaJ-paaF-tesB (black line) and an empty vector (grey line). The peak 
corresponding to 3-hydroxyadipate is indicated with a black arrow. c Cultivation profile of C. glutamicum harboring pZ8-Ptac showing  OD600 (filled 
circles) and residual sugar (empty circles). N = 3; error bars = standard deviation. (d) Ion (m/z = 145.0506) extracted chromatogram obtained by LC/
MS of adipic acid standard (purple), cultivation broth of C. glutamicum harboring pZ8-paaH-ter-paaJ-paaF-tesB (green), pZ8-paaH-tesB-paaJF (grey), 
and an empty vector (black)
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challenges need to be overcome when engineering C. glu-
tamicum for adipic acid production.
Conclusions
The present study demonstrated the feasibility of the syn-
thetic reverse β-oxidation pathway by showcasing adipic 
acid biosynthesis in C. glutamicum. This work laid the 
groundwork for future development of C. glutamicum 
as a microbial factory for adipic acid production. For the 
subsequent studies, metabolic flux should be engineered 
to overcome the present bottleneck represented by dehy-
dration of 3-hydroxyadipyl-CoA, while chromosomal 
deletion of catabolic genes will bring further advantages.
Methods
Strains and plasmids
Primers (Additional file  6: Table  S3) used in this study 
were synthesized at Eurofins Genomics (Ebersberg, Ger-
many), Thermo Fisher (Waltham, MA, USA) or Sigma-
Aldrich (St. Louis, MO, USA). Codon-optimization for C. 
glutamicum (Additional file 2: Table S2) and subsequent 
gene synthesis were carried out at GenScript (Piscataway, 
NJ, USA). All constructed vectors were sequence-verified 
at Eurofins Genomics or Macrogen Europe (Amsterdam, 
the Netherlands). Plasmid pZ8-Ptac (Addgene plasmid 
number 74,064) was a gift from Timothy Lu (MIT, Cam-
bridge, MA, USA) [54]. General PCR conditions were 
as follows: 95  °C for 5  min; 28 cycles at 95  °C for 30  s, 
55  °C for 30  s, 72  °C for 1 min; and a final extension at 
72 °C for 7 min. The PCR was carried out with Phusion 
High-Fidelity DNA Polymerase (Thermo Fisher) in a total 
reaction volume of 50 µL. All restriction enzymes were 
purchased from Thermo Fisher. E. coli  NEB®5-alpha and 
 NEB®10-beta from New England Biolabs (Ipswich, MA, 
USA) were used for general cloning purposes. The C. glu-
tamicum ATCC 13,032 strain used in this study is a lab 
stock. Chemicals used in this study were purchased from 
Merck (Kenilworth, NJ, USA) or Thermo Fisher.
pZ8-paaJ-tesB was constructed by cloning codon-opti-
mized paaJ and tesB into the pZ8-Ptac vector. Primers 
134_F_EcoRI and 133_i3R_KpnI v2 were used to amplify 
paaJ and the product was digested with EcoRI/KpnI. 
Primers tesB_F_KpnI and tesB_R_BamHI were used 
to amplify tesB and the product was digested with 
KpnI/BamHI. pZ8-Ptac was digested with EcoRI/BamHI 
and subsequently three-way ligated with the two PCR 
products. A 16-bp RBS (tttcacacaggaaaca) from the syn-
thetic lacUV5 promoter was placed between paaJ and 
tesB for tesB expression during this step.
Construction of pZ8-HB was carried out by replac-
ing ter from pZ8-Hr with tesB. Codon-optimized tesB 
was PCR-amplified with primers tesB_F_KpnI and 
tesB_R_BamHI, and then digested with KpnI/BamHI. 
This fragment was ligated into pZ8-Hr previously 
digested with KpnI/BamHI to replace ter. An extra pro-
moter and paaJ were amplified by primers PA146F_Gib 
and PA146R_Gib using pZ8-paaJ as template, and then 
inserted into pZ8-HB by Gibson assembly to yield 
pZ8-paaH-tesB-paaJ.
Trans-2-Hexenedioic acid producing vector, pZ8-
paaH-tesB-paaJF, was created by adding an extra pro-
moter, paaJ, and paaF fragments to already prepared 
pZ8-HB. The promoter, paaJ, and paaF was PCR ampli-
fied using the primers, 143_F_Gibson and 143_R_Gib, 
and introduced into BamHI digested pZ8-HB.
Vector pZ8-paaH-ter-paaJ-paaF-tesB was con-
structed in a stepwise manner. A codon-optimized ver-
sion of E. coli paaH was PCR-amplified using primers 
133_i1F_EcoRI and 133_i1R_KpnI (Additional file  6: 
Table  S3), and then digested with EcoRI and KpnI. 
A codon-optimized version of T. denticola ter was 
PCR-amplified using primers 133_i2F_KpnI and 133_
i2R_BamHI and digested with KpnI and BamHI. The 
digested PCR products were three-way ligated with 
EcoRI/BamHI-digested pZ8-Ptac to yield pZ8_Hr. A 
16-bp untranslated region (UTR) sequence (tttcaca-
caggaaaca) [55] including an RBS was introduced 
between the two genes for codon-optimized ter expres-
sion. To construct pZ8_HrJF, an extra tac promoter, 
codon-optimized paaJ, and paaF were introduced 
into pZ8_Hr. The codon-optimized version of paaJ 
was PCR-amplified using primers pre132_i3F_BamHI 
and 133_i3R_KpnI v2, and subsequently digested with 
BamHI/KpnI. The codon-optimized paaF fragment 
(PCR-amplified with primers 133_i4F_KpnI and 133_
i4R_PstI v2) was digested with KpnI/PstI. Digested 
paaJ and paaF fragments were subsequently three-
way ligated into pZ8_Hr previously digested with 
BamHI/PstI. As with pZ8_Hr, an additional 16-bp UTR 
(tttcacacaggaaaca) with RBS was introduced at this 
point to allow for paaF expression. Thus, an extra pro-
moter was PCR-amplified with primers tac_BamHI_F 
and tac_BamHI_R, digested with BamHI, and then 
ligated upstream of paaJ at the BamHI site. The result-
ing plasmid was named pZ8_HrJF. For pZ8-paaH-ter-
paaJ-paaF-tesB construction, the tesB gene was added 
to pZ8_HrJF. Codon-optimized tesB was PCR-amplified 
using primers 133_i5F_PstI and 133_i5R_PstI, and then 
digested with PstI. The resulting fragment was ligated 
into pZ8_HrJF at the PstI site downstream of paaF.
pZ8-paaJ was constructed by removing tesB from pZ8-
paaJ-tesB. This was achieved by digesting pZ8-paaJ-tesB 
with KpnI and BamHI, followed by ligation, whereby a 
short linker was placed at the 3′ end of paaJ as KpnI and 
BamHI were not compatible. The linker consisted of oli-
gos linker_sense and linker_antisense (Additional file  6: 
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Table S3). This step introduced also an XbaI site between 
KpnI and BamHI for potential future usage.
Pathway intermediate standards
Standards of pure 3-oxoadipic acid (O856825) and 
3-hydroxyadipic acid (H943100) were purchased from 
Toronto research chemicals (North York, ON, Canada). 
Trans-2-hexenedioic acid was synthesized by our group 
during a previous study [70].
Media
Pre-culture medium included (per liter): 40 g brain heart 
infusion, 10  g glucose, and 20  g D-sorbitol. Flask cul-
tivation medium included (per liter): 25  g glucose, 2  g 
 MgSO4·7H2O, 1  g  K2HPO4, 1  g  KH2PO4, 1  g urea, 20  g 
 (NH4)2SO4, 10  g yeast extract, 0.65  mg  (NH4)6Mo7O24, 
7.726 mg  CaCl2·2H2O, 11.35 µg biotin, 4.57 mg thiamin, 
9 mg  FeSO4·7H2O, 7.88 mg  MnSO4·H2O, 5.5 mg  CuSO4· 
 5H2O, 10.06 mg  ZnSO4·7H2O, and 1.88 mg  NiCl2·6H2O. 
Additionally, 20  g/L of  CaCO3 was added to each flask 
as buffer and  CaCO3 was removed by diluted HCl 
post-cultivation.
Cultivation conditions
Cultivation was carried out in 100-mL Erlenmeyer flasks 
at 30 °C and 200 rpm in a shaking incubator (KS 4000 I 
control; IKA-Werke GmbH, Staufen im Breisgau, Ger-
many). Each strain was maintained in 60 % glycerol solu-
tion and was inoculated in 5 mL pre-culture medium. 
After 17–19  h, when  OD600 reached 5.5–6.0, 1 mL of 
pre-culture was spun down at 3000 rcf and the pellet 
was resuspended in 25 mL of cultivation medium. When 
applicable, isopropyl β-d-1-thiogalactopyranoside at a 
final concentration of 1 mM was added at  OD600 0.5–0.8. 
Neomycin at a final concentration of 50 µg/L was added 
as a selective marker during each cultivation.
Cell growth and routine metabolite analysis
Cell growth during cultivation was monitored by measur-
ing  OD600 on a Genesys 20 spectrophotometer (Thermo 
Fisher).
The concentration of glucose and organic acids in cul-
tivation broth was analyzed by a Jasco (Tokyo, Japan) 
LC-4000 high-performance liquid chromatography sys-
tem equipped with an autosampler (AS-4150), a pump 
(PU-4180), a column oven (CO-4061), a UV detector 
(RI-4030), and an RI detector (UV-4075). The mobile 
phase consisted of 5 mM  H2SO4 and was pumped at 
constant flow rate of 0.8 mL/min. A Rezex ROA-organic 
acid H + column (Phenomenex, Torrance, CA, USA) 
maintained at 80  °C was used to separate the metabo-
lites in the cultivation broth. The concentration of each 
compound was determined by Jasco ChomNAV software 
(version 2.03.03).
Confirmation of 3‑hydroxyadipic acid by GC/MS analysis
3-hydroxyadipic acid was identified by GC/MS as 
reported previously with minor modifications [19, 71]. 
Briefly, 40 µL of cell-free cultivation broth was lyophi-
lized, resuspended in 50 µL pyridine, and reacted with 50 
µL MeOX (20 g/L in pyridine) for 120 min at 30 °C. The 
metabolites were then derivatized with 50 µL MSTFA at 
60 °C for 1 h prior to injection.
The GC/MS system was equipped with a Focus GC 
(Thermo Fisher), ISQ MS, and PAL COMBI-xt autosam-
pler. A Zebron ZB-5MS column (Phenomenex) was used, 
with 1.1 mL/min gas flow and helium as the carrier gas. 
The column temperature gradient was as follows: initial 
hold at 60 °C for 1 min; ramp at 10 °C/min to 325 °C; and 
final hold at 325  °C for 10  min. Equilibration time was 
0.5  min and preparatory run time out was 10  min. The 
inlet temperature was 250 °C. The electron multiplier was 
operated at 70  eV with scanning acquisition mode. In 
total, 1 µL of sample was injected for each analysis with 
split-less mode. The ion (MS) source was set at 250  °C, 
mass filter (MS Quad) at 150 °C, and MS transfer line at 
290 °C.
Solid‑phase extraction
For sample clean up, 33  μm polymeric reverse-phased 
solid-phase extraction (SPE) column (200  mg/3 mL; 
8B-S100-FBJ) was used with minor modification from 
manufacturer’s protocols (Phenomenex). The precondi-
tion and equilibration steps were according to the man-
ufacturer’s protocols. The 5 mL of cell-free cultivation 
broth was pretreated with final 1 % of formic acid prior 
to loading to the column. The column was washed with 1 
mL water and eluted with 1 mL methanol. Methanol was 
removed by evaporation prior to next steps.
Detection of trans‑2‑hexenedioic acid and adipic acid 
by LC‑MS
For detection of adipic acid and trans-2-hexenedioic 
acid, SPE treated samples were analyzed using LC-MS. 
A Dionex Ultimate 3000 RS UPLC with a diode array 
detector (DAD) was coupled to a Bruker Maxis QTOF 
MS with electrospray ionization (ESI) (Bruker Dalton-
ics, Bremen, Germany). The system was equipped with a 
reversed phase column (Kinetex; 1.7 μm, F5, 100 Å, 150 
mm × 2.1 mm; Phenomenex) and was maintained at 
40 °C. Gradient elution was utilized for separation and a 
constant flow rate of 400 µL/min was held throughout the 
run. Two eluents were used in the gradient elution: elu-
ent A (H2O, 20 mM formic acid) and eluent B (ACN, 20 
mM formic acid). The gradient started with 10 % eluent 
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B rising to 70 % over 6.7 min, followed by 70–100 % elu-
ent B over 1.3 min, then held at 100 % eluent B for 3 min. 
Analysis was carried out in negative ESI. The scan range 
was m/z 75–1250 with 2 spectra per second. For the tar-
geted fragmentation a collision energy of 15 eV was used.
Prior to the analysis of samples, the QTOF-MS was 
calibrated using a sodium formate calibrant. In addition, 
all data files were recalibrated with an internal standard 
of sodium formate injected prior to initial sample elution 
for each sample.
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